EDESA BIOTECH, INC. Basic Shares Outstanding (Weighted Average)
EDESA BIOTECH, INC. (EDSA) reported Basic Shares Outstanding (Weighted Average) of 9.01 million shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfSharesOutstandingBasic · last filed 2026-08-13
- EDESA BIOTECH, INC. weighted average number of shares outstanding, basic for the quarter ending 2026-06-30 was 9.01M shares, a 28.26% increase year-over-year.
- EDESA BIOTECH, INC. weighted average number of shares outstanding, basic for the quarter ending 2026-03-31 was 8.54M shares, a 60.98% increase year-over-year.
- EDESA BIOTECH, INC. weighted average number of shares outstanding, basic for the quarter ending 2025-12-31 was 7.97M shares, a 138.33% increase year-over-year.
- EDESA BIOTECH, INC. weighted average number of shares outstanding, basic for the quarter ending 2025-09-30 was 7.05M shares, a 117.22% increase year-over-year.
- EDESA BIOTECH, INC. weighted average number of shares outstanding, basic for fiscal 2025 was 5.68M shares, a 77.54% increase from fiscal 2024.
- EDESA BIOTECH, INC. weighted average number of shares outstanding, basic for fiscal 2024 was 3.20M shares, a 11.84% increase from fiscal 2023.
- EDESA BIOTECH, INC. weighted average number of shares outstanding, basic for fiscal 2023 was 2.86M shares.
- EDESA BIOTECH, INC. weighted average number of shares outstanding, basic for fiscal 2016 was 8.83M shares, a 10.93% increase from fiscal 2015.
| Period end | Weighted Average Number of Shares Outstanding, Basic 1 month | Weighted Average Number of Shares Outstanding, Basic 1 month as first filed | Weighted Average Number of Shares Outstanding, Basic 3 month | Weighted Average Number of Shares Outstanding, Basic 3 month as first filed | Weighted Average Number of Shares Outstanding, Basic 6 month | Weighted Average Number of Shares Outstanding, Basic 9 month | Weighted Average Number of Shares Outstanding, Basic 9 month as first filed | Weighted Average Number of Shares Outstanding, Basic 12 month |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | 9.01M shares 10-Q · filed 2026-08-13 | 8.77M shares derived: average of 2 quarters · filed 2026-08-13 | 8.50M shares 10-Q · filed 2026-08-13 | 8.14M shares derived: average of 4 quarters · filed 2026-08-13 | ||||
| 2026-03-31 | 8.54M shares 10-Q · filed 2026-05-14 | 8.25M shares 10-Q · filed 2026-05-14 | 7.86M shares derived: average of 3 quarters · filed 2026-05-14 | 7.65M shares derived: average of 4 quarters · filed 2026-08-13 | ||||
| 2025-12-31 | 7.97M shares 10-Q · filed 2026-02-13 | 7.51M shares derived: average of 2 quarters · filed 2026-02-13 | 7.35M shares derived: average of 3 quarters · filed 2026-08-13 | 6.84M shares derived: average of 4 quarters · filed 2026-08-13 | ||||
| 2025-09-30 | 7.05M shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-12-12 | 7.04M shares derived: average of 2 quarters · filed 2026-08-13 | 6.46M shares derived: average of 3 quarters · filed 2026-08-13 | 5.68M shares 10-K · filed 2025-12-12 | ||||
| 2025-06-30 | 7.02M shares 10-Q · filed 2026-08-13 | 6.16M shares derived: average of 2 quarters · filed 2026-08-13 | 5.22M shares 10-Q · filed 2026-08-13 | 4.73M shares derived: average of 4 quarters · filed 2026-08-13 | ||||
| 2025-03-31 | 5.31M shares 10-Q · filed 2026-05-14 | 4.31M shares 10-Q · filed 2026-05-14 | 3.97M shares derived: average of 3 quarters · filed 2026-05-14 | 3.78M shares derived: average of 4 quarters · filed 2026-05-14 | ||||
| 2024-12-31 | 3.35M shares 10-Q · filed 2026-02-13 | 3.30M shares derived: average of 2 quarters · filed 2026-02-13 | 3.27M shares derived: average of 3 quarters · filed 2026-02-13 | 3.25M shares derived: average of 4 quarters · filed 2026-02-13 | ||||
| 2024-09-30 | 3.25M shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-12-12 | 3.23M shares derived: average of 2 quarters · filed 2025-12-12 | 3.22M shares derived: average of 3 quarters · filed 2025-12-12 | 3.20M shares 10-K · filed 2025-12-12 | ||||
| 2024-06-30 | 3.22M shares 10-Q · filed 2025-08-08 | 3.21M shares derived: average of 2 quarters · filed 2025-08-08 | 3.18M shares 10-Q · filed 2025-08-08 | 3.14M shares derived: average of 4 quarters · filed 2025-08-08 | ||||
| 2024-03-31 | 3.19M shares 10-Q · filed 2025-05-14 | 3.16M shares 10-Q · filed 2025-05-14 | 3.12M shares derived: average of 3 quarters · filed 2025-05-14 | 3.07M shares derived: average of 4 quarters · filed 2025-05-14 | ||||
| 2023-12-31 | 3.13M shares 10-Q · filed 2025-02-14 | 3.08M shares derived: average of 2 quarters · filed 2025-02-14 | 3.03M shares derived: average of 3 quarters · filed 2025-02-14 | |||||
| 2023-09-30 | 3.03M shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-12-13 | 2.98M shares derived: average of 2 quarters · filed 2024-12-13 | 2.86M shares 10-K · filed 2024-12-13 | |||||
| 2023-06-30 | 2.93M shares 10-Q · filed 2024-08-09 | 2.80M shares 10-Q · filed 2024-08-09 | ||||||
| 2016-09-30 | 10.03M shares derived: 10-K 12 month − 10-Q 9 month · filed 2016-12-14 | 9.24M shares derived: average of 2 quarters · filed 2016-12-14 | 8.83M shares 10-K · filed 2016-12-14 | |||||
| 2016-06-30 | 8.45M shares 10-Q · filed 2016-08-09 | 8.42M shares 10-Q · filed 2016-08-09 | ||||||
| 2015-09-30 | 7.97M shares derived: 10-K 12 month − 10-Q 9 month · filed 2016-12-14 | 7.96M shares derived: average of 2 quarters · filed 2016-12-14 | 31.82M shares derived: average of 3 quarters · filed 2016-12-14 | 7.96M shares 10-K · filed 2016-12-14 | ||||
| 2015-06-30 | 7.95M shares 10-Q · filed 2016-08-09 | 79.55M shares 10-Q · filed 2015-08-10 | 43.75M shares derived: average of 2 quarters · filed 2016-08-09 | 7.95M shares 10-Q · filed 2016-08-09 | 79.52M shares 10-Q · filed 2015-08-10 | |||
| 2015-03-31 | 79.55M shares 10-Q · filed 2015-05-11 | 79.50M shares 10-Q · filed 2015-05-11 | ||||||
| 2014-12-31 | 79.46M shares 10-Q · filed 2015-02-09 | |||||||
| 2014-09-30 | 7.87M shares 10-K · filed 2016-12-14 | 78.68M shares 10-Q · filed 2015-02-09 | ||||||
| 2014-08-31 | 7.58M shares 10-K · filed 2016-12-14 | |||||||
| 2014-06-30 | 76.24M shares 10-Q · filed 2015-08-10 | 76.24M shares derived: average of 2 quarters · filed 2015-08-10 | 76.30M shares 10-Q · filed 2015-08-10 | |||||
| 2014-03-31 | 76.24M shares 10-Q · filed 2015-05-11 | 76.30M shares 10-Q · filed 2015-05-11 | ||||||
| 2013-12-31 | 73.98M shares 10-Q · filed 2015-02-09 | |||||||
| 2013-08-31 | 5.16M shares 10-K · filed 2015-12-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B |